CryoLife (United States)
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CryoLife (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
48%
Total
Publications
147
Total Open
Publications
70
Total
Citations
3.3K
Open Access
Percentage
48%
Total
Publications
147
Total Open
Publications
70
Total
Citations
3.3K
Breakdown
Publisher Open
34%
Both
11%
Other Platform Open
3%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 11%
7
Hybrid 65%
43
No Guarantees 24%
16
Other Platform Open
Domain 80%
16
Preprint 15%
3
Public 10%
2
Other Internet 10%
2
Institution 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 16 |
Europe PMC | Domain | 7 |
Semantic Scholar | Public | 2 |
California Digital Library - eScholarship | Other Internet | 2 |
arXiv | Preprint | 2 |
OSF Preprints - ECSarXiv | Preprint | 1 |